about
Implementation of a national measles elimination program in Iran: Phylogenetic analysis of measles virus strains isolated during 2010-2012 outbreaksVaccine-associated paralytic poliomyelitis in immunodeficient children, Iran, 1995-2008.Risk Factors of Delay Proportional Probability in Diphtheria-tetanus-pertussis Vaccination of Iranian Children; Life Table Approach AnalysisSurvival Analysis for Predictive Factors of Delay Vaccination in Iranian Children.Comparing Seasonal Pattern of Laboratory Confirmed Cases of Pertussis with Clinically Suspected Cases.The cost effectiveness of rotavirus vaccination in IranDevelopment and Optimization of a Homemade ELISA Kit for Detection of Antibodies Against Haemophilus influenzae Type bVaccine-Derived Polioviruses and Children with Primary Immunodeficiency, Iran, 1995-2014.Factors affecting the seroconversion rate of 12-month-old babies after the first injection of measles vaccine in the southeast of IranBudget impact analysis of vaccination against Haemophilus influenzae type b as a part of a Pentavalent vaccine in the childhood immunization schedule of IranCost-effectiveness analysis of the introduction of rotavirus vaccine in Iran.Adverse events following immunization with pentavalent vaccine: experiences of newly introduced vaccine in Iran.Molecular analysis of the bacille Calmette-Guérin vaccine strain currently being used in Iran.The First Macrolide-Resistant Bordetella pertussis Strains Isolated From Iranian Patients.Seroprevalence of poliovirus antibodies among 7-month-old infants after 4 doses of oral polio vaccine in Sistan-va-Baluchestan, Islamic Republic of Iran.Correction to: Adverse events following immunization with pentavalent vaccine: experiences of newly introduced vaccine in IranThe use of oral fluid samples spotted on filter paper for the detection of measles virus using nested rt-PCR.Successful control and impending elimination of measles in the Islamic Republic of Iran.Head-to-head immunogenicity comparison of Edmonston-Zagreb vs. AIK-C measles vaccine strains in infants aged 8-12 months: A randomized clinical trial.Role of National Immunization Technical Advisory Group on improvement of immunization programmes in the Islamic Republic of Iran.Seroprevalence of antibodies to measles and rubella eight months after a vaccination campaign in the southeast of Iran.Syringe-type and needle gauge have no role in adverse events following DTwP immunization: a randomized multicenter trial.Surveillance of HIV drug resistance transmission in Iran: experience gained from a pilot study.Progress in Measles and Rubella Elimination in IranCost-Effectiveness Analysis of the Introduction of HPV Vaccination of 9-Year-Old-Girls in IranVaccine-associated paralytic poliomyelitis in a patient with MHC class II deficiencyInadvertent rubella vaccination of pregnant women: evaluation of possible transplacental infection with rubella vaccineSero-epidemiological evaluation of rubella immunity among pre-marriage women in IranCost-Effectiveness of Rotavirus Vaccination for Under-Five Children in Iran
P50
Q35149515-56AFBFBD-FC86-4736-AE56-F0B39C66B06BQ35877053-B67565D8-1789-47F9-A8AE-79E83A270BB8Q36409693-927D3629-F4DF-426F-AEEF-4A749B3F6FEEQ36529282-5F1C52C3-DBDD-4174-97B1-98A2978AC4F3Q36850265-66A8D179-74C9-4748-A136-69EA0515D7B0Q37135008-4C182784-3E26-4E84-B1A5-637385935822Q37158016-2E7E2141-DA18-4C3B-920A-0F6C1D2F31EAQ37288126-61F7E474-3D37-44B3-A76C-F227813650F8Q37560983-9229DF2D-98EC-4462-A916-45222295A6A7Q37587145-38A49CB5-7F31-4758-9C50-BFFC0748EFC5Q38445972-949F98DA-85CD-4E9A-BD52-36FC050567E2Q38611378-DA6CB9AC-C49B-438D-8C77-28A4921027FBQ40824125-3F9A5CD0-5A24-4929-BFE7-5F7A5BB1CFD7Q41676251-1DF4027E-41C2-461D-99F6-287D16129F6AQ42148419-EFE12B41-C6F8-4363-92B4-91B3285F2796Q42370514-C4E9264E-33BD-410C-8547-0AC935F4CF15Q45357383-5006DEE4-6882-4B4B-875D-C5151B181056Q46948339-99D0C34F-C72D-4DC0-BC08-7C1C25F40739Q47559485-44F88FC9-E042-4939-824A-6B5AD1D12C7DQ48829001-38812BED-AEDE-46F4-81AE-38B0082554CFQ50116269-A8A4C7AF-5C0B-42EE-A3FF-FBDBF4B302C8Q51826731-92501AE5-07C2-4FC5-83D6-8F82ABEDC37EQ54700120-4011A3F5-B8E3-44D6-A4C1-C974D5ED45DCQ58050484-33086390-18CE-42F3-90C4-BDF35F7396DFQ64137937-D2C2BCA6-0DA8-4B2A-B16F-214090E7A386Q80351488-7E5F9B24-A16C-4A9A-909E-EF4372E05BFBQ82697394-BDA58D0A-D062-40C0-A114-584DB7C6FAFDQ90489492-E2A0DDC1-332E-4D47-A03F-44AEEA5F2FF8Q95815768-F19902B8-85F1-469D-9C4F-FE062880A01D
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Seyed Mohsen Zahraei
@ast
Seyed Mohsen Zahraei
@en
Seyed Mohsen Zahraei
@es
Seyed Mohsen Zahraei
@nl
type
label
Seyed Mohsen Zahraei
@ast
Seyed Mohsen Zahraei
@en
Seyed Mohsen Zahraei
@es
Seyed Mohsen Zahraei
@nl
prefLabel
Seyed Mohsen Zahraei
@ast
Seyed Mohsen Zahraei
@en
Seyed Mohsen Zahraei
@es
Seyed Mohsen Zahraei
@nl
P106
P1153
26031213200
P31
P496
0000-0002-1940-2216